BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 16842322)

  • 21. Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B.
    Wong GL; Wong VW; Choi PC; Chan AW; Chan HL
    Aliment Pharmacol Ther; 2010 May; 31(10):1095-103. PubMed ID: 20180785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of non-invasive indices for liver histology in patients with chronic hepatitis B].
    Chen YP; Zhu YF; Feng XR; Peng J; Hou JL
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1181-3. PubMed ID: 15485795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
    J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.
    Fabris C; Smirne C; Toniutto P; Colletta C; Rapetti R; Minisini R; Falleti E; Pirisi M
    Clin Biochem; 2006 Apr; 39(4):339-43. PubMed ID: 16487951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing routine and serum markers of liver fibrosis in CHB patients using parallel and serial interpretation.
    Hongbo L; Xiaohui L; Hong K; Wei W; Yong Z
    Clin Biochem; 2007 May; 40(8):562-6. PubMed ID: 17362902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection.
    Pohl A; Behling C; Oliver D; Kilani M; Monson P; Hassanein T
    Am J Gastroenterol; 2001 Nov; 96(11):3142-6. PubMed ID: 11721762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C.
    Imperiale TF; Said AT; Cummings OW; Born LJ
    Am J Gastroenterol; 2000 Sep; 95(9):2328-32. PubMed ID: 11007237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers. A prospective study.
    Elsebae MM; Abu-Zekri NB
    Int J Surg; 2008 Oct; 6(5):362-6. PubMed ID: 18662898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
    Castéra L; Le Bail B; Roudot-Thoraval F; Bernard PH; Foucher J; Merrouche W; Couzigou P; de Lédinghen V
    J Hepatol; 2009 Jan; 50(1):59-68. PubMed ID: 19013661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
    Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
    J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can aspartate aminotransferase to platelet ratio index replace liver biopsy in chronic hepatitis C?
    El-Sayed R; Fahmy M; El Koofy N; El-Raziky M; El-Hawary M; Helmy H; El-Akel W; El-Hennawy A; El-Karaksy H
    Trop Gastroenterol; 2011; 32(4):267-72. PubMed ID: 22696906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
    Peng D; Han Y; Ding H; Wei L
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1082-8. PubMed ID: 18707599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.
    Al-Mohri H; Cooper C; Murphy T; Klein MB
    HIV Med; 2005 Nov; 6(6):375-8. PubMed ID: 16268817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection.
    Ma J; Jiang Y; Gong G
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):428-34. PubMed ID: 23358121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.